Cargando…

Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis

Detalles Bibliográficos
Autores principales:	Ishigatsubo, Y, Takeno, M, Kirino, Y, Mizuki, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599877/ http://dx.doi.org/10.1186/1546-0096-13-S1-P166

Ejemplares similares

Functional analysis of macrophages in Behçet's disease
por: Nakano, H, et al.
Publicado: (2015)

Clinical Course before and after Cataract and Glaucoma Surgery under Systemic Infliximab Therapy in Patients with Behçet's Disease
por: Nishida, Tomomi, et al.
Publicado: (2011)

Infliximab for severe ocular inflammation in patients with Behcet's disease
por: Sfikakis, P, et al.
Publicado: (2003)

Use of Adalimumab in young patients with chronic uveitis in whom infliximab loses its efficacy
por: Giani, TG, et al.
Publicado: (2008)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
por: Bracaglia, C, et al.
Publicado: (2008)

Infliximab in the treatment of refractory uveitis. Does dose really matter?
por: Sukumaran, MD Sukesh, et al.
Publicado: (2011)

Aortitis and uveitis. A challenging case of Takayasu or Behcet disease?
por: Di Landro, Giancarla, et al.
Publicado: (2014)

Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease
por: Kirino, Yohei, et al.
Publicado: (2008)

PW03-014 - TLR4 and MEFV variants are Behçet's risk factors
por: Kirino, Y, et al.
Publicado: (2013)

Adalimumab in the management of Behçet’s disease
por: Ueda, Atsuhisa, et al.
Publicado: (2015)

Identification of ERAP1 protein allotypes in the Turkish population and evaluation of their contributions to Behçet's disease risk
por: Remmers, EF, et al.
Publicado: (2015)

Reconstitution of disrupted photoreceptor layer in uveitis associated with Behçet’s disease by infliximab treatment
por: Takeuchi, Masaru, et al.
Publicado: (2015)

PReS-FINAL-2313: Clinical experiences of therapy in pediatric patients with Behcet uveitis, singe center study
por: Sozeri, B, et al.
Publicado: (2013)

PW03-011 – New Behçet's loci and gene-gene interactions
por: Remmers, EF, et al.
Publicado: (2013)

A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
por: Horiguchi, Noe, et al.
Publicado: (2020)

Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet’s disease in Japan
por: Soejima, Yutaro, et al.
Publicado: (2021)

Ten-year follow-up of infliximab treatment for uveitis in Behçet disease patients: A multicenter retrospective study
por: Takeuchi, Masaru, et al.
Publicado: (2023)

Immune Reactions in Behçet's Disease
por: Kaneko, Fumio, et al.
Publicado: (2014)

Behçet's Uveitis
por: Tugal-Tutkun, Ilknur
Publicado: (2009)

PReS-FINAL-2112: Mapping the treatment effect of infliximab on a case of refractory anterior uveitis related to juvenile idiopathic arthritis (JIA)
por: Miranda, V, et al.
Publicado: (2013)

Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease
por: Alfawaz, Abullah, et al.
Publicado: (2014)

Twenty Years of Quiescence after Nonstop Remicade(®) (Infliximab) Infusions in a Child with Ocular Behçet Disease Presenting as Hypopyon-Anterior Uveitis Refractory to Immunosuppressants
por: Evereklioglu, Cem
Publicado: (2023)

Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis
por: Ishido, Mizuho, et al.
Publicado: (2017)

Infusion reaction to infliximab biosimilar after transitioning from infliximab
por: Kashlan, Reem, et al.
Publicado: (2020)

Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review
por: Valdes, Lianna, et al.
Publicado: (2022)

Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years
por: Baraliakos, X, et al.
Publicado: (2005)

Behcet Disease: treatment of vascular involvement in children
por: Bilginer, Y, et al.
Publicado: (2008)

PW03-013 - Behçet's disease: genotype-phenotype correlations
por: Takeuchi, M, et al.
Publicado: (2013)

Efficacy of abatacept in juvenile idiopathic arthritis related uveitis
por: Katargina, LA, et al.
Publicado: (2011)

Behçet’s Disease Uveitis
por: Joubert, Morgane, et al.
Publicado: (2023)

Anakinra for secondary amyloidosis in an adolescent with FMF and Behcet Disease
por: Bilginer, Y, et al.
Publicado: (2008)

Recommendations for the Management of Neuro-Behçet's Disease by the Japanese National Research Committee for Behçet's Disease
por: Hirohata, Shunsei, et al.
Publicado: (2020)

Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients
por: Cantini, Fabrizio, et al.
Publicado: (2012)

Infliximab-Related Infusion Reactions: Systematic Review
por: Lichtenstein, Lev, et al.
Publicado: (2015)

Efficacy of high dose methotrexate in pediatric auto-immune uveitis
por: Armbrust, Wineke, et al.
Publicado: (2014)

Aortic Arch Aneurysm in Behçet Disease Successfully Treated with Infliximab
por: Nishiyama, Taihei, et al.
Publicado: (2020)

Identification of kinectin as a novel Behcet's disease-related autoantigen
por: Lu, Y, et al.
Publicado: (2003)

May antihistone antibodies replace antinuclear antibodies (ANA) as a predictor of uveitis in Juvenile idiopathic arthritis?
por: Nordal, EB, et al.
Publicado: (2008)

Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
por: Rivarola, C, et al.
Publicado: (2008)

PReS-FINAL-2150: Antiocular antibodies in children with juvenile idiopathic arthritis-associated uveitis
por: Walscheid, K, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1hsqbnl4uhps87pj0682q3s9ch